Characterization of tolerance to the anti-leakage effect of formoterol in rat airways

European Journal of Pharmacology

Volumn 338, Issue 1, 1997, Pages 83-87

  Bowden, Jeffrey J ^a   Anderson, Gary P ^a   Lefevre, Peter M ^a   Sulakvelidze, Irakly ^a   McDonald, Donald M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2 Adrenergic agonist; Plasma leakage; Substance P; Trachea; Vascular permeability

Indexed keywords

ADRENERGIC RECEPTOR; FORMOTEROL; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; ENDOTHELIUM CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; TRACHEA;

ADRENERGIC BETA-AGONISTS; ANIMALS; CAPILLARY PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; ETHANOLAMINES; MALE; RATS; RATS, INBRED F344; SUBSTANCE P; TRACHEA;

EID: 0030669620     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01272-7     Document Type: Article

References (16)

1. 2-adrenoceptor agonist bronchodilator. Life Sci. 52:1993;2145-2160.
2. Avner B.P., Noland B. In vivo desensitisation to beta receptor mediated bronchodilator drugs in the rat: Decreased beta receptor affinity. J. Pharmacol. Exp. Ther. 207:1978;23-33.
3. 2 adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Am. J. Physiol. 266:1994;L461-L468.
4. Barnes P.J. Beta-adrenergic receptors and their regulation. Am. J. Resp. Crit. Care Med. 152:1995;838-860.
5. Bhagat R., Kalra S., Swystun V.A., Cockroft D.W. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest. 108:1995;1235-1239.
6. Bottcher I., Kienzle R., Pignat W. Beta-agonist-induced tachyphylaxis in mouse skin. Agents Actions. 23:1988;86-88.
7. 2-adrenergic agonist formoterol. J. Appl. Physiol. 77:1994;397-405.
8. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. New Engl. J. Med. 327:1992;1198-1203.
9. Chong L.K., Morice A.H., Yeo W.F., Schleimer R.P., Peachell P.T. Functional desensitisation of β agonist responses in human lung mast cells. Am. J. Respir. Cell Mol. Biol. 13:1995;540-546.
10. Collins S., Caron M.G., Lefkowitz R.J. From ligand binding to gene expression: New insights into the regulation of G-protein-coupled receptors. Trends Pharmacol. Sci. 17:1992;37-39.
11. 2-adrenoceptor agonist formoterol. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;576-588.
12. Lipworth B.J., Struthers A.D., McDevitt D.G. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am. Rev. Resp. Dis. 140:1989;586-592.
13. 2-adrenergic receptor facilitate sequestration. Biochemistry. 35:1996;4155-4160.
14. Nishikawa M., Mak J.C.W., Shirasaki H. Long term exposure to nor-epinephrine results in down-regulation and reduced mRNA expression of pulmonary β-adrenergic receptors in guinea pigs. Am. J. Resp. Cell. Mol. Biol. 10:1994;91-99.
15. Sulakvelidze I., McDonald D.M. Anti-edema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves. Am. J. Resp. Crit. Care Med. 149:1994;232-238.
16. Whelan C.J., Vardey C.J., Johnson M. Inhibition of vascular permeability by salmeterol in guinea-pig lung is not subject to desensitisation. Am. J. Resp. Crit. Care Med. 147:1993;A62.